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XRCC3 THR241MET POLYMORPHISM INFLUENCE ON NUCLEAR BUDS FREQUENCY IN 
EXPOSED TO FORMALDEHYDE
AIM OF THE STUDY
Determine whether there is an in vivo association 
between the XRCC3 Met 241 Thr polymorphism 
and the mean of nuclear buds (NBUD) in 
occupationally workers exposed to formaldehyde
INTRODUCTION
Formaldehyde (FA), also known as formalin, formal and methyl aldehydes, is a colorless, flammable, strong-smelling gas. It has an
important application in embalming tissues and that result in exposures for workers in the pathology anatomy laboratories and
mortuaries. Occupational exposure to FA has been shown to induce nasopharyngeal cancer and has been classified as carcinogenic to
humans (group 1) on the basis of sufficient evidence in humans and sufficient evidence in experimental animals. Manifold in vitro studies
clearly indicated that FA is genotoxic. FA induced various genotoxic effects in proliferating cultured mammalian cells. The cytokinesis-
block micronucleus (CBMN) assay was originally developed as an ideal system for measuring micronucleus (MN), however it can also be
used to measure nucleoplasmic bridges (NBP) and nuclear buds (NBUD). Over the past decade another unique mechanism of micronucleus
formation, known as nuclear budding has emerged. NBUDS is considered as a marker of gene amplification and/or altered gene dosage
because the nuclear budding process is the mechanism by which cells removed amplified and/excess DNA. Shimizu et al. (1998) showed
that amplified DNA is localised selectively to specific sites at the periphery of the nucleus and eliminated via nuclear budding to form MN
during the S phase of cell cycle. The gene XRCC3 is involved in homologous recombination repair of cross-links and chromosomal double-
strand breaks and at least one polymorphism has been reported in codon 241, a substitution of a methionine for a threonine.
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CONCLUSIONS
NBUD should be considered as a genotoxic biomarker, with an origin comparable to that of MN. It appears to originate from interstitial or
terminal acentric fragments, possibly representing nuclear membrane entrapment of DNA that has been left in cytoplasm after nuclear
division, or excess of DNA that is being extruded from the nucleus. Chromosomal instability has been associated to XRCC3 gene mutation
and other genes involved in repair. Manifold studies suggest a direct role of XRCC3 Thr241Met polymorphism maybe associated, but not
significant, to a reduce capacity of DNA repair.
C LADEIRA 1,2    MC GOMES 3   M BRITO 1
1 – Escola Superior de Tecnologia da Saúde de Lisboa – Instituto Politécnico de Lisboa
2 – Centro de Investigação e Estudos em Saúde Pública – Universidade Nova de Lisboa
3 – Faculdade de Ciências – Universidade de Lisboa
R
E
S
U
L
T
S
The mean of NBUD was higher in exposed workers (0.98±0.273) in comparison with controls (0.07±0.028), a statistically significant 
difference (Mann-Whitney test, p<0.001). Binary logistic regression indicated that the exposure to FA was an important variable affecting 
the frequency of NBUD and the polymorphism of XRCC3 at codon 241 were found statistically significant (p=0.006). The exposed workers 
carrying the Thr/Met XRCC3 241 genotype were found to have higher mean NBUD (1,50 vs 0,21) and in controls it was the Met/Met
genotype, NBUD (0,20 vs 0,03). Met/Met (OR=4.342, 95% CI 1.087-17.339) and Thr/Met (OR= 5.864, 95% CI 1.648-20.865) polymorphisms 
showed to be risk factors in comparison with Thr/Thr.
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METHODOLOGY
The study was carried out in Portugal in a
sample of 56 workers occupationally exposed to
FA in pathology anatomy laboratories and in 85
non-exposed subjects.
The evaluation of the frequency of NBUD was
conducted by applying cytokinesis blocked
micronucleus assay in peripheral blood
lymphocytes
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Distribution of NBUD mean according to XRCC3 Thr 241 Met 
polymorphism
NBUD 0,38 1,5 0,24 0,2 0,04 0,03
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